75
Participants
Start Date
April 30, 2005
Primary Completion Date
October 31, 2008
Study Completion Date
September 30, 2010
Oncolytic adenovirus (serotype 5) - CG0070
Intravesical administration of CG0070 (in suspension) directly into the bladder
Columbia University, New York
New York Oncology Hematology, Albany
Cancer Centers of the Carolinas, Greenville
Billings Clinic, Billings
Mary Crowley Medical Research Center, Dallas
Baylor College of Medicine, Houston
BCG Oncology, Phoenix
UCSF Comprehensive Cancer Center, San Francisco
Male/Female Health and Research Centre, Barrie
The Fe/Male Health Centre, Oakville
Lead Sponsor
Cell Genesys
INDUSTRY